ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Ms. Sara - What is it?

Patient basic information Patient: Ms. Sara Allen) Nationality: Portugal Disease diagnosis: Breast cancer Clinical hospital: H0O Treatment: Blood stem cell transplant + chemotherapy Accommodation days: 152 days Treatment cost: about 1309095 yuan Treatment effect: Healing Description of the disease Ms. Sara is from Portugal and was diagnosed with breast cancer locally.

Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, escort and on-site services throughout the treatment process. The MDT Expert Group uses a comprehensive set of blood stem cell transplants + chemotherapy, and during the treatment the medical team closely monitors the patient's indicators and dynamic adjustment programs. After 152 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard.

Treatment results The patient finally recovered. When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track recovery through the remote follow-up system. 'Mrs.

Sara Liu, experts have criticized the case as a typical case of cross-border suspected seriousness clinical disease. Liu4 Liu is a multidisciplinary collaborative mechanism that has developed a blood stem cell transplant + chemotherapy program for breast cancer, reflecting the comprehensive strength of Chinese hospitals in the field of suspected disease clinics and a summary of how international medical services are regulated.

葡萄牙,乳腺癌,哈尔滨医科大学附属第一医院,国际医疗,来华就医,中国医疗